Busuito Michael J MD is categorized under Family Practice Doctors in Troy, MI and active since 1988.
Busuito Michael J MD was established in 1988, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Busuito at the company’s single location by writing to 1080 Kirts Boulevard # 700, Troy, Michigan MI 48084 or by phoning (248) 362-2300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Busuito Michael J MD |
Contact Person: | Michael Busuito |
Address: | 1080 Kirts Boulevard # 700, Troy, Michigan 48084 |
Phone Number: | (248) 362-2300 |
Website Address: | metrodetroitplasticsurgery.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1988 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Family Practice Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Busuito Michael J MD was started in 1988 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Busuito for inquiries that concern Busuito Michael J MD by calling the company number (248) 362-2300, as your correspondence is most welcome. Additionally, the physical location of the single location of Busuito Michael J MD can be found at the coordinates 42.55665,-83.162322 as well as the street address 1080 Kirts Boulevard # 700 in Troy, Michigan 48084.
For its online presence, you may visit Busuito Michael J MD’s website at metrodetroitplasticsurgery.com and engage with its social media outlets through on Twitter and on Facebook.